Candel Therapeutics (CADL) Earnings Date & Reports
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CADL is expected to report earnings to rise 84.78% to -16 cents per share on November 06
Q3'25
Est.
$-0.17
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.50
Q4'24
Missed
by $0.10
Q4'23
Missed
by $0.20
The last earnings report on August 14 showed earnings per share of -9 cents, beating the estimate of -15 cents. With 681.71K shares outstanding, the current market capitalization sits at 326.63M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CADL showed earnings on August 14, 2025. You can read more about the earnings report here.